素HCl装载的纳米结构脂质载体用于鼻至大脑输送:香油的优化和协同作用
Avinash R Tekade1, Prasad V Kadam2, Manoj K Aswar2
1Marathwada Mitra Mandal's College of Pharmacy, Thergaon (Kalewadi), Pune, 411033, M.S.), India. avitekade@gmail.com.
Journal of molecular neuroscience : MN
|September 28, 2025
概括
这项研究开发了使用沙夫兰油用于直接输送到大脑的内Fluoxetine HCl纳米结构脂质载体. 这种新的方法增强了抗抑郁药的有效性,并最大限度地减少了全身副作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 纳米技术 纳米技术
- 神经科学是一个神经科学.
背景情况:
- 抑郁症是一种普遍的精神疾病,口服抗抑郁药的生物可用性有限.
- 素HCl (FH) 具有较低的口服生物利用率 (28%) 和全身副作用.
- 需要新的药物输送系统来改善大脑向和减少副作用.
研究的目的:
- 开发和评估内纳米结构脂质载体 (NLC) 系统,用于素HCl (FH).
- 为了利用沙夫兰油 (SO) 作为一种功能性脂质,以增强鼻至大脑的输送.
- 为了最大限度地减少与常规FH管理相关的全身副作用.
主要方法:
- 使用高压均质化和超声波制备FH-NLC.
- 配方根据颗粒大小,PDI,药物负载和捕获效率进行了优化.
- 鉴定包括TEM,SEM,XRD,DSC,体外释放,体外透和组织病理学.
主要成果:
- 优化的FH-NLC显示出用于鼻至脑输送的理想特征 (117.3 nm大小,0.219 PDI,-44.76 mV ZP).
- 实现了高的药物加载和捕获效率,并持续在体外释放.
- 活体研究表明鼻透性增强,其组织病理学证实了安全性. 药理学表明,抗抑郁药具有协同作用.
结论:
- 鼻内FH-SO NLCs为抑郁症治疗中直接针对大脑提供了一个有希望的策略.
- 这种方法可以提高治疗效果,同时减轻系统性副作用.
- 以香油为基础的NLCs代表了针对大脑的抗抑郁药物的新且有效的输送系统.
相关概念视频
01:27Bioavailability Enhancement: Drug Permeability Enhancement
186
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
186
01:16Bioavailability Enhancement: Drug Solubility Enhancement
221
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
221
01:23Antidepressant Drugs: MAOIs and Other Agents
828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
01:22Drug Delivery: Miscellaneous Routes
713
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
713
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.6K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.6K
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
200
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200